Daniel D. Karp

19k citations
186 papers · 14.8k · 8 hit papers · h-index 50

Impact in

Papers in

Daniel D. Karp

184 papers receiving 14.1k citations

Daniel D. Karp's Hit Papers

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials 2023 · 278 citations
2780+12+24Years since publication5001k1.5k

Peers

Daniel D. Karp
Comparison fields: 5 of 138
  • Pulmonary and Respiratory Medicine 4.1k
  • Oncology 2.6k
  • Biochemistry 729
  • Otorhinolaryngology 552
  • Cancer Research 1.3k
Replace Phyllis J. Goodman with:
Phyllis J. Goodman United States
Laurence H. Baker United States
Mimi C. Yu United States
Eric Winquist Canada
Mary E. Reid United States
Howard L. Parnes United States
Pär E. Stattin Sweden
Leslie G. Ford United States
Wael Sakr United States
John A. Glaspy United States
Daniel D. Karp relative to Phyllis J. Goodman United States Phyllis J. Goodman's profile →
Citations per field
00.5×2×4×5.4×
Phyllis J. Goodman · 1×
Citations per year

Countries citing papers authored by Daniel D. Karp

Since Specialization
Citations

This map shows the geographic impact of Daniel D. Karp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Karp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Karp more than expected).

Fields of papers citing papers by Daniel D. Karp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Karp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Karp. The network helps show where Daniel D. Karp may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel D. Karp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel D. Karp Line = papers co-authored together Daniel D. Karp links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers
Hit paper breakdown →
20081734
2
Vitamin E and the Risk of Prostate Cancer
Hit paper breakdown →
20111450
3
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
Hit paper breakdown →
20001197
4
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
Hit paper breakdown →
19901173
5
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer
Hit paper breakdown →
2003959
6
Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
Hit paper breakdown →
2004924
7 1993312
8 2005301
9
Targeting RET in Patients With RET -Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
Hit paper breakdown →
2017301
10 2016283
11
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
Hit paper breakdown →
2023278
12 2001260
13 1993248
14 2016200
15 2005183
16 1996172
17
Differentiation patterns in the blastic phase of chronic myeloid leukemia.
1983171
18 2016167
19 2020143
20 2017142

About Daniel D. Karp

Daniel D. Karp is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Otorhinolaryngology, having authored 186 papers that have together received 14.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Cancer Immunotherapy and Biomarkers (26 papers), Cancer Genomics and Diagnostics (18 papers), Lung Cancer Diagnosis and Treatment (15 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Head and Neck Cancer Studies (7 papers) and Nuclear Structure and Function (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.1k citations), Oncology (2.6k citations), Biochemistry (729 citations), Otorhinolaryngology (552 citations) and Cancer Research (1.3k citations). Daniel D. Karp has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Waun Ki Hong, R. Lotan, Philip Bonomi, Everett E. Vokes, Mark S. Huberman, David R. Gandara, Vincent A. Miller, James R. Rigas, Lisa A. Hammond and David S. Hong. Their work appears in journals such as Cancer, Clinical Cancer Research, Annals of Oncology, Investigational New Drugs and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact